Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategies for mucosal vaccine development.

P N Boyaka1, M Marinaro, J L Vancott

  • 1Department of Microbiology, The Immunobiology Vaccine Center, University of Alabama at Birmingham, 35294-2170, USA.

The American Journal of Tropical Medicine and Hygiene
|May 27, 1999
PubMed
Summary

Developing mucosal vaccines is crucial for fighting infectious diseases. This review explores adjuvants and delivery systems to improve mucosal immunity, aiming for safer and more effective vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of immune and microbial environments is independently regulated in the mammary gland.

Mucosal immunology·2018
Same author

Nanogel-based nasal ghrelin vaccine prevents obesity.

Mucosal immunology·2017
Same author

Critical role of TSLP-responsive mucosal dendritic cells in the induction of nasal antigen-specific IgA response.

Mucosal immunology·2016
Same author

Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.

Mucosal immunology·2015
Same author

S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge.

Avian diseases·2014
Same author

Transcription factor Spi-B-dependent and -independent pathways for the development of Peyer's patch M cells.

Mucosal immunology·2012

Area of Science:

  • * Immunology
  • * Vaccinology
  • * Infectious Disease Research

Background:

  • * Secretory IgA and systemic immunity are vital for combating pathogens.
  • * Mucosal vaccines offer a promising strategy by activating immune cells at mucosal inductive sites.
  • * This approach can induce protective immunity in both mucosal and systemic compartments.

Purpose of the Study:

  • * To critically review current adjuvants and delivery systems for mucosal immunization.
  • * To highlight the importance of understanding mucosal immunity regulation for vaccine design.
  • * To guide the development of safer and more effective mucosal vaccines.

Main Methods:

  • * Comprehensive literature review of adjuvants and delivery systems for mucosal vaccines.
  • * Analysis of cellular and molecular factors regulating mucosal immunity.

Related Experiment Videos

  • * Synthesis of current research trends in mucosal vaccine development.

    • Main Results:

    • * Adjuvants and novel delivery systems are key areas of investigation for enhancing mucosal vaccine efficacy.
    • * Understanding the regulatory mechanisms of mucosal immunity is essential for targeted vaccine design.
    • * Current strategies aim to elicit specific protective immune responses against various pathogens.

    Conclusions:

    • * Advances in understanding mucosal immunity are critical for designing next-generation vaccines.
    • * Improved adjuvants and delivery systems are needed to optimize mucosal vaccine performance.
    • * The ultimate goal is to develop safer vaccines that induce robust, pathogen-specific protective immunity.